Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1047986.RA3_ANLp4Xt2-G7EssD1vLloHFd78SV1f79Mk1FStpzq4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1047986.RA3_ANLp4Xt2-G7EssD1vLloHFd78SV1f79Mk1FStpzq4130_assertion type Assertion NP1047986.RA3_ANLp4Xt2-G7EssD1vLloHFd78SV1f79Mk1FStpzq4130_head.
- NP1047986.RA3_ANLp4Xt2-G7EssD1vLloHFd78SV1f79Mk1FStpzq4130_assertion description "[Taken together, these data show that adiponectin treatment can inhibit the oncogenic actions of leptin through blocking its downstream signaling molecules and raising adiponectin levels could be a rational therapeutic strategy for breast carcinoma in obese patients with high leptin levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1047986.RA3_ANLp4Xt2-G7EssD1vLloHFd78SV1f79Mk1FStpzq4130_provenance.
- NP1047986.RA3_ANLp4Xt2-G7EssD1vLloHFd78SV1f79Mk1FStpzq4130_assertion evidence source_evidence_literature NP1047986.RA3_ANLp4Xt2-G7EssD1vLloHFd78SV1f79Mk1FStpzq4130_provenance.
- NP1047986.RA3_ANLp4Xt2-G7EssD1vLloHFd78SV1f79Mk1FStpzq4130_assertion SIO_000772 23358729 NP1047986.RA3_ANLp4Xt2-G7EssD1vLloHFd78SV1f79Mk1FStpzq4130_provenance.
- NP1047986.RA3_ANLp4Xt2-G7EssD1vLloHFd78SV1f79Mk1FStpzq4130_assertion wasDerivedFrom befree-2016 NP1047986.RA3_ANLp4Xt2-G7EssD1vLloHFd78SV1f79Mk1FStpzq4130_provenance.
- NP1047986.RA3_ANLp4Xt2-G7EssD1vLloHFd78SV1f79Mk1FStpzq4130_assertion wasGeneratedBy ECO_0000203 NP1047986.RA3_ANLp4Xt2-G7EssD1vLloHFd78SV1f79Mk1FStpzq4130_provenance.